Moderna, Inc. is among the Top 10 AI-Powered Biotech Stocks to Buy Now, specializing in mRNA therapeutics and vaccines, including the COVID-19 vaccine. The company faced a 7% stock drop in September 2025 due to reports linking the vaccine to child deaths, despite citing extensive real-world data and emphasizing safety.

Moderna, Inc. is expanding beyond COVID-19 with mRNA therapies for influenza, RSV, and cancer, integrating AI and machine learning to accelerate R&D. Despite market challenges, the company’s focus on safety and transparency enhances public trust and regulatory engagement, positioning it among the best biotech stocks for future healthcare needs.

Read more at Yahoo Finance: Moderna, Inc. (MRNA) Advances Flu, RSV, and Cancer mRNA Therapies Beyond COVID